Investor Presentation March 2023
Company Overview
Inotiv, Inc. is a growing contract research organization ("CRO")
focused on driving innovation and discovery for the world's
leading biopharmaceutical companies and medical research
organizations
We provide a comprehensive suite of high quality research
science, models and services, participating with our clients in the
discovery and development of novel therapeutics
Our full spectrum solutions span two segments:
>
Discovery and Safety Assessment ("DSA")
Research Models and Services ("RMS")
We reduce the cost and time to bring new drugs to market
We were founded in 1974 and reinvented in 2017, when current
leadership launched a new strategic plan and vision for the
company
Headquarters
West Lafayette, IN
1974
Year Formed
Employees
Customers
Exchange/Ticker
>2,100
~3,500
NASDAQ/NOTV
$7.07
Shares (fully diluted)
~30 million
Market Cap.* (3/1/23)
~$180 million
* Basic shares
Recent Price (3/1/2023)
3View entire presentation